胰腺癌与乙型肝炎感染的研究进展

doi:10.16139/j.1007-9610.2020.02.018

摘要/Abstract

中图分类号:

R735.9

孙文韬, 邓侠兴. 胰腺癌与乙型肝炎感染的研究进展[J]. 外科理论与实践, 2020, 25(02): 171-173.

SUN Wentao, DENG Xiaxing. Advances in study on association between pancreatic carcinoma and hepatitis B virus[J]. Journal of Surgery Concepts & Practice, 2020, 25(02): 171-173.

参考文献 29

[30]	Wei XL, Luo HY, Li CF, et al. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers[J]. Int J Cancer, 2017, 141(1):152-159. doi: 10.1002/ijc.30719 URL
[31]	Wei XL, Qiu MZ, Chen WW, et al. The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer[J]. J Transl Med, 2013, 11:249. doi: 10.1186/1479-5876-11-249 URL
[32]	Dumitrascu T, Pineau P, Dima S, et al. Impact of hepatitis B virus on clinicopathological features and outcomes after resection for pancreatic adenocarcinoma[J]. Anticancer Res, 2015, 35(9):5123-5128. pmid: 26254417
[33]	Zhou X, Wang X, Duan J, et al. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas[J]. Pathol Res Pract, 2019, 215(2):343-346. doi: 10.1016/j.prp.2018.12.016 URL
[34]	Oksüzoğlu B, Kiliçkap S, Yalcin S. Reactivation of he- patitis B virus infection in pancreatic cancer: a case report[J]. Jpn J Clin Oncol, 2002, 32(12):543-545. pmid: 12578904
[35]	孙德聪, 陈丽, 吴志勇, 等. 化疗相关乙肝病毒再激活的诊治现状[J]. 中国临床药理学与治疗学, 2014, 19(5):584-590.
[1]	Hassan MM, Li D, El-Deeb AS, et al. Association between hepatitis B virus and pancreatic cancer[J]. J Clin Oncol, 2008, 26(28):4557-4562. doi: 10.1200/JCO.2008.17.3526 pmid: 18824707
[2]	Wang DS, Chen DL, Ren C, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer[J]. Int J Cancer, 2012, 131(2):461-468. doi: 10.1002/ijc.26376 URL
[3]	Ben Q, Li Z, Liu C, et al. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China[J]. Pancreas, 2012, 41(3):435-440. doi: 10.1097/MPA.0b013e31822ca176 URL
[4]	Desai R, Patel U, Sharma S, et al. Association between hepatitis B infection and pancreatic cancer: a population-based analysis in the United States[J]. Pancreas, 2018, 47(7):849-855. doi: 10.1097/MPA.0000000000001095 URL
[5]	Zhu F, Li HR, Du GN, et al. Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China[J]. Asian Pac J Cancer Prev, 2011, 12(6):1405-1408.
[6]	Chang MC, Chen CH, Liang JD, et al. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma[J]. World J Gastroenterol, 2014, 20(17):5060-5065. doi: 10.3748/wjg.v20.i17.5060 URL
[7]	Iloeje UH, Yang HI, Jen CL, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study[J]. Liver Int, 2010, 30(3):423-429. doi: 10.1111/j.1478-3231.2009.02147.x URL
[8]	Tang J, Sharma R, Lamerato L, et al. Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma[J]. J Clin Gastroenterol, 2014, 48(8):729-733. doi: 10.1097/MCG.0000000000000111 URL
[9]	Krull AS, Inoue M, Sawada N, et al. Hepatitis B and C virus infection and risk of pancreatic cancer: a population-based cohort study (JPHC Study CohortⅡ)[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(3):555-557. doi: 10.1158/1055-9965.EPI-15-1115 URL
[10]	Huang J, Magnusson M, Törner A, et al. Risk of pancrea- tic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden[J]. Br J Cancer, 2013, 109(11):2917-2923. doi: 10.1038/bjc.2013.689 URL
[11]	Andersen ES, Omland LH, Jepsen P, et al. Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus[J]. J Viral Hepat, 2015, 22(10):828-834. doi: 10.1111/jvh.12391 URL
[12]	Xing S, Li ZW, Tian YF, et al. Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(6):575-583. doi: 10.1016/S1499-3872(13)60091-0 URL
[13]	Luo G, Hao NB, Hu CJ, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis[J]. Cancer Causes Control, 2013, 24(3):529-537. doi: 10.1007/s10552-012-0144-2 URL
[14]	Fiorino S, Chili E, Bacchi-Reggiani L, et al. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis[J]. Pancreatology, 2013, 13(2):147-160. doi: 10.1016/j.pan.2013.01.005 pmid: 23561973
[15]	Wang Y, Yang S, Song F, et al. Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis[J]. Eur J Cancer Prev, 2013, 22(4):328-334. doi: 10.1097/CEJ.0b013e32835b6a21 URL
[16]	Xu JH, Fu JJ, Wang XL, et al. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies[J]. World J Gastroenterol, 2013, 19(26):4234-4241. doi: 10.3748/wjg.v19.i26.4234 URL
[17]	Dejean A, Lugassy C, Zafrani S, et al. Detection of he- patitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus[J]. J Gen Virol, 1984, 65(Pt 3):651-655. doi: 10.1099/0022-1317-65-3-651 URL
[18]	Hoefs JC, Renner IG, Askhcavai M, et al. Hepatitis B surface antigen in pancreatic and biliary secretions[J]. Gastroenterology, 1980, 79(2):191-194. pmid: 7399225
[19]	Jin Y, Gao H, Chen H, et al. Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues[J]. Cancer Lett, 2013, 335(2):447-454. doi: 10.1016/j.canlet.2013.03.001 URL
[20]	Hohenberger P. The pancreas as target organ for hepatitis B virus--immunohistological detection of HBsAg in pancreatic carcinoma and chronic pancreatitis[J]. Leber Magen Darm, 1985, 15(2):58-63. pmid: 3887078
[21]	Fiorino S, Visani M, Acquaviva G, et al. Search for HBV and HCV genome in cancer cells of pancreatic tumors[J]. Pancreas, 2016, 45(1):e12-e14.
[22]	Pang Y, Kartsonaki C, Guo Y, et al. Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies[J]. Int J Cancer, 2017, 140(8):1781-1788. doi: 10.1002/ijc.30599 URL
[23]	Kirkegård J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2017, 112(9):1366-1372. doi: 10.1038/ajg.2017.218 pmid: 28762376
[24]	Brooks-Worrell B, Palmer JP. Immunology in the clinic review series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation[J]. Clin Exp Immunol, 2012, 167(1):40-46. doi: 10.1111/j.1365-2249.2011.04501.x pmid: 22132883
[25]	Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma[J]. J Hepatol, 2016, 64(1 Suppl):S84-S101. doi: 10.1016/j.jhep.2016.02.021 URL
[26]	Chen Y, Bai X, Zhang Q, et al. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway[J]. Cancer Lett, 2016, 380(1):98-105. doi: 10.1016/j.canlet.2016.06.011 URL
[27]	Fiorino S, Bacchi-Reggiani L, Pontoriero L, et al. Tensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection[J]. JOP, 2014, 15(2):151-164.
[28]	Zou J, Chen J, Xie X, et al. Hepatitis B virus infection is a prognostic biomarker for better survival in operable esophageal cancer: analysis of 2004 patients from an endemic area in China[J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(6):1028-1035. doi: 10.1158/1055-9965.EPI-18-1095 URL
[29]	Tanase AM, Dumitrascu T, Dima S, et al. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(2):162-172. doi: 10.1016/S1499-3872(14)60026-6 URL

胰腺癌与乙型肝炎感染的研究进展

Advances in study on association between pancreatic carcinoma and hepatitis B virus

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 29

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张莹莹, 李华, 管佳琴, 等. 乳腺癌患者术后早期上肢淋巴水肿的发生率及影响因素分析 [J]. 组织工程与重建外科杂志, 2023, 19(3): 242-.
[2]	聂海行, 王帆, 王红玲, 赵秋. ERCP术后胰腺炎的危险因素及预防方法[J]. 外科理论与实践, 2023, 28(04): 310-315.
[3]	朱颖, 汤玉茗, 黄佳, 章永平, 姚玮艳. 全反式维A酸可促进肿瘤相关诱导配体对多种胰腺癌细胞的凋亡作用[J]. 内科理论与实践, 2023, 18(03): 171-176.
[4]	于岚, 张永怡, 黄雷, 万歆, 姜胜耀, 唐思静, 张俊, 胡伟国. 老年病人胰十二指肠切除术后严重并发症发生的危险因素[J]. 外科理论与实践, 2023, 28(02): 139-146.
[5]	杨蕊馨, 杜宇童, 燕然林, 朱正纲, 李琛, 于颖彦. 消化道肿瘤单细胞转录组测序研究中生物样本前处理改良的探索[J]. 诊断学理论与实践, 2022, 21(05): 567-574.
[6]	郑毓真, 郑彦俊, 周易, 祁星, 陈薇薇, 史雯, 周伟君, 杨之涛, 陈影, 毛恩强, 陈尔真. 综合性医院674例脓毒症住院患者的回顾性临床分析[J]. 内科理论与实践, 2022, 17(04): 278-282.
[7]	尹彦江, 罗治文, 陈晓, 张业繁, 黄振, 赵宏, 赵建军, 李智宇, 周健国, 蔡建强, 毕新宇. 肝内胆管癌病人肝脏手术切缘与预后的关系[J]. 外科理论与实践, 2022, 27(03): 221-228.
[8]	黄晓敏, 章倩莹, 杨俪, 崔岩, 徐天, 王子秋, 王朝晖, 任红, 张春燕. 腹膜透析患者跌倒发生的现况调查[J]. 内科理论与实践, 2022, 17(03): 248-252.
[9]	史曼曼, 王语欣, 马毓华, 王朝晖. 系统性红斑狼疮的遗传学研究进展[J]. 内科理论与实践, 2022, 17(03): 267-272.
[10]	丁燕飞, 忻笑容, 周郁芬, 谢玲, 谷雷雷, 吴云林, 陈平. 上消化道溃疡伴出血患者溃疡愈合延迟的危险因素分析[J]. 诊断学理论与实践, 2022, 21(03): 312-316.
[11]	卞秀娟, 包志瑶, 陈虹, 承璐潇, 石宝平. 血流感染耐碳青霉烯类肺炎克雷伯菌患者的死亡危险因素分析[J]. 内科理论与实践, 2022, 17(01): 73-77.
[12]	何敏, 刘颖斌. 可切除胰腺癌的判断标准与治疗及其争议[J]. 外科理论与实践, 2022, 27(01): 6-10.
[13]	吴莉莉, 许耀麟, 楼文晖. 放射治疗在胰腺癌治疗中的应用现状和展望[J]. 外科理论与实践, 2022, 27(01): 25-29.
[14]	王冲, 程石. 可切除胰腺癌术前减黄的共识与争议[J]. 外科理论与实践, 2022, 27(01): 30-33.
[15]	卫积书, 黄诗朦. 胰腺癌嗜神经侵袭与神经重塑的研究历史和治疗现状[J]. 外科理论与实践, 2022, 27(01): 42-45.